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Abstract
Cardiovascular diseases represent the main cause of morbidity and mortality 
worldwide. Obesity, sedentary life style, diet, smoking and stress are the principal 
inducers of hypertension, endothelium dysfunction and insulin resistance in the 
developed countries. The latest in vitro and in vivo studies on different type of 
extracts obtained from black-fruited Aronia highlight its excellent cardioprotective 
actions for the prevention and treatment of cardiovascular and metabolic disor-
ders. So, this chapter aims to bring an up-to-date regarding the antioxidant, anti-
inflammatory, anti-atherosclerotic, antiplatelet, blood pressure, glucose and lipid 
reduction properties of black-fruited Aronia, as a possible new therapeutic strategy 
for the primary and secondary prevention of cardiovascular pathologies.
Keywords: black chokeberries, cardioprotective, black-fruited Aronia, antioxidant, 
anti-atherosclerotic, antithrombotic
1.  Black chokeberries: historical background, taxonomy and botanical 
aspects
The use of medicinal plants in the prevention and treatment of diseases is an 
old practice that has been maintained over time and is currently being given special 
attention by scientists, as well as by people aiming to preserve their health or treat 
a disease. In the past, the therapeutic properties of the plants were discovered by 
observing their effects on the animals that ate them [1–3]. People gathered knowl-
edge about the therapeutic effects of plants and several traditional medicines were 
born [4]. At the beginning of the nineteenth century, the first plant compounds 
were isolated and later some of them served as a model for the development of 
synthetic drugs [4, 5]. Plant-derived products are intensively studied and they are 
Natural Products - From Bioactive Molecules to Human Health
2
important sources in drug discovery [1]. Studies are directed toward the identifica-
tion of mechanisms of action of plant compounds [6], exploiting their capacity of 
reducing the side effects of synthetic drugs [7] and development of new delivery 
systems that can increase the efficacy of phytochemicals [8].
One of the plants whose health benefits led to numerous studies is black choke-
berry, also known as black-fruited Aronia. Its fruits enjoy presently a high recogni-
tion as a health food, despite lacking the historical advantage of other well-known 
rosaceous berry crops (strawberries, raspberries and blackberries). The highly 
regarded berries (botanically: pomes), cultivated in many European countries and 
North America, have an unusual history, which reflects on the taxonomic confu-
sions surrounding the plant.
Unlike other edible plants, black Aronia spread from America to Europe due to 
its decorative interest. The ancestor of today’s cultivated black-fruited Aronia is 
Aronia melanocarpa (Michx.) Elliott, a species that grows wildly in North America 
[9] along with two other Aronia species. The small genus Aronia Medik. (choke-
berry) includes multistemmed, deciduous shrubs that differ in the color and size 
of fruits (pomes), as well as in the pubescence of leaves, stems and inflorescences. 
Three North American and one European species are recognized [10]. Red choke-
berry, A. arbutifolia (L.) Pers., grows up to 3 m tall and has obovate to elliptical 
leaves, which are shiny green on the upper side and tomentose, slightly gray on the 
lower side. The margins are serrated and the tip is short, acuminate. Flowers are 
white, in compound corymbs. In late September to early October, red fruits are 
produced. Black chokeberry, A. melanocarpa (Michx.) Elliott, has a smaller habit 
(up to 1.5 m) and is not pubescent [11]. Its fruits are black, shiny, with a diameter of 
0.8–1.3 cm; they typically ripen in August. A third species native to North America, 
A. prunifolia (Marshall) Rehder, or purple chokeberry, is considered by certain 
authors to be a hybrid between the former two species, a distinct species or a variety 
of black or red chokeberry. It has dark purple to black fruits, and the leaf pubes-
cence is intermediate between A. arbutifolia and A. melanocarpa [12].
A. melanocarpa is cold-hardy member of the Rosaceae family, where it is 
assigned to the Amygdaloideae subfamily and Maleae tribe [13]. Wild-growing 
black chokeberry plants were introduced to Europe in the nineteenth century 
as ornamental shrubs. The first record of the species in Russia (1816) mentions 
black Aronia under the name Mespilus melanocarpa in the catalog of plants of the 
Kremenets Botanical Garden [14]. Soon, it was grown as a cold-resistant ornament 
in other botanical gardens; before the twentieth century, it was however not grown 
for its fruits, which, though edible, are poorly palatable and astringent. The black-
fruited Aronia is cultivated nowadays as a distinct morphology in comparison to its 
wild-growing North American counterparts: its leaves are wider, flowers are larger 
and more numerous, fruits have a larger diameter, and corymbs bear a higher num-
ber of fruits [15]. It has been proposed that this species is the result of breeding and 
selection experiments performed in the early twentieth century by Ivan Michurin, 
and that all Aronia plants cultivated in the former Soviet Union originate from the 
Russian pomologist’s nursery [14]. Then, it spread to other European countries such 
as Poland, Norway, Finland, Sweden or Germany [16]. In 1976, chokeberry was 
introduced to Japan [17]. The distinct differences from its wild-growing progenitors 
and the constancy in characteristics supported the assignment of the large-fruited 
chokeberry to a new species, Aronia mitschurinii A.K.Skvortsov & Maitul [18]. 
Its origin is however not completely elucidated. One of the hypotheses is that the 
species is a hybrid obtained by backcrossing A. melanocarpa with an F1 xSorbaro-
nia hybrid (Sorbus aucuparia × A. melanocarpa). Leonard and co-workers using 
amplified fragment length polymorphism (AFLP) were able to show similarities of 
A. mitschurinii to xSorbaronia hybrids [19]. Further studies with more sensitive and 
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complex tools (like multilocus nuclear data) are proposed in order to firmly estab-
lish the origin of A. mitschurinii [20].
An important feature of the cultivated black-fruited Aronia is its extremely low 
variability due to the apomictic formation of seeds, a process occurring without fer-
tilization of the egg. Plants resulting from apomixis are clones of the mother plant. 
Cultivated varieties of A. mitschurinii, including ‘Nero,’ ‘Viking’ and ‘Galicjanka,’ 
have in fact undistinguishable phenotypes [21] and are tetraploid (2n = 68) [14]. 
On the contrary, ‘Hugin’ and ‘Elata’ cultivars are considered true A. melanocarpa 
genotypes [21].
Taking into account the better understanding of Aronia taxonomy and genetics, 
in recent years, it has become accepted that the cultivated black-fruited Aronia 
berries, which were the subject of most biomedical and phytochemical studies, are 
not A. melanocarpa fruits as reported. Research results should rather be assigned to 
A. mitschurinii, which is the only species used for commercial fruit production [21].
Further developments on the subject of black-fruited Aronia taxonomy should 
certainly lead to a more stable and correct nomenclature of the chokeberry species 
investigated by biomedical research. A unified, proper nomenclature is essential to 
enable researchers to assign correctly a therapeutic activity to A. melanocarpa, A. 
mitschurinii, or even X Sorbaronia mitschurinii, all of them used in various publica-
tions to assign cultivated black-fruited chokeberry.
2. Traditional use of black chokeberries
Although wild-growing black chokeberries (Aronia melanocarpa) were known 
to the North American settlers, the taste of the fruits was dissuading for a use as 
foodstuff. They employed fruits and bark as an astringent. The Forest Potawatomi 
Native Americans used the fruits of this plant in cold treatment and the preparation 
of traditional pemmican [17].
In Russia and Lithuania, the cultivated black chokeberry fruits were used as 
adjuvant treatment for high blood pressure and as anti-atherosclerotic agent [22]. 
Other uses include treatment of hemorrhoids, achlorhydria, avitaminosis and 
convalescence [17].
Because of their astringent taste, black chokeberry fruits are not usually con-
sumed as such, but they are used for the production of juices, wines, teas, jellies or 
syrups, especially in fruit blends [23, 24]. Chokeberry powders are used as a natural 
dye in the food industry [25].
The high content of phenolic compounds, mainly anthocyanins, which are 
responsible for the black color of the fruits, determined an increased interest in 
the medicinal properties of this plant. Aronia ssp. fruits have a higher antioxidant 
activity than other berries. Various studies emphasized antioxidant, anticancer, 
anti-diabetic, anti-inflammatory and hepatoprotective properties for the juice or 
fruit extract, which made cultivated black-fruited Aronia an important health food 
and dietary supplement [26].
3. Phytochemistry
Several analyses have been performed in order to evaluate the organic as well as 
inorganic constituents of black chokeberries. They include the research of the dif-
ferences in the chemical composition of wild vs. cultivated chokeberry [21, 27], the 
influence of the cultivar type [28–30], the degree of fruit maturity [31], fertilization 
[32], the application of biosynthesis regulators [33] and geographic location [34]. 
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Wild Aronia genotypes contain less water and more phenolics and have a higher 
antioxidant activity than cultivated black chokeberries [21]. Typical values for the 
dry weight of cultivated black chokeberry fruits are 17.9–26%; fresh chokeberries 
afford 11.1–17.4% juice and 44.6–50% pomace [35]. The majority (72%) of the 
dry weight is constituted by dietary fiber, higher than other fruits like bilberries 
and currants. The study of dietary fiber with solid-state NMR could show that its 
components are water-insoluble fibers (cellulose, hemicellulose, lignin, cutin and 
pectins), soluble fibers and other constituents, which are valuable antioxidants, 
anthocyanins and procyanidins [36].
The sour taste of Aronia ssp. berries is due to the presence of organic acids, 
mainly malic and citric acids. Their total content is however lower than in other 
berries [37]. Cultivated black chokeberries contain between 5.71 and 19.36% 
reducing sugars [23] and are characterized by a relatively high sorbitol amount 
(median content of 70 g/kg) [34] when compared to other berries. The high sorbi-
tol content, shared as well by rowan berries (Sorbus aucuparia), may be related to 
the possible hybrid nature of cultivated chokeberry. Large-fruited Aronia cultivars 
have been hypothesized to contain the genomes of Aronia melanocarpa and Sorbus 
aucuparia in a ratio of 3:1 [19, 21]. The high sorbitol content has been proposed 
to serve as an analytical tool in the control of juice blends [38]. Another feature 
of the sugar profile in cultivated black chokeberry is the absence of sucrose; its 
presence in black Aronia-based products suggests the addition of sugar or other 
fruits [34].
The lipid content of black cultivated chokeberries is reduced (below 0.2%) [23] 
and is mainly owed to hydrophobic constituents of the skin and seeds. The content 
in proteins is also low, with values of 10.7% in the pomace. The main amino acid was 
glutamic acid (19.8%), followed by aspartic acid (8.9%) and arginine (7.9%) [39].
Regarding the content in minerals, chokeberries may be valuable to complement 
dietary potassium and zinc intake. Among vitamins, Aronia fruits contain vita-
mins B1, B2, B6 and C, pantothenic acid and niacin; the detailed content has been 
extensively reviewed [23, 38].
The analysis of the volatile constituents in Aronia berry juice afforded the 
detection of 74 constituents, of which the most abundant were 3-penten-2-one, 
3,9-epoxy-p-menth-1-ene and benzaldehyde. Among the aroma-active compounds, 
ethyl-2-methyl butanoate, ethyl-3-methyl butanoate and ethyl decanoate could 
account for the “fruity” aroma notes, while nonanal is responsible for the “green” 
notes [40]. The bitter-almond scent of the fruits is due to the presence of amygdalin 
[34]. This compound is a cyanogenic glycoside present in many representatives 
of the Rosaceae family [35]. Interestingly, a recent research aimed at identifying 
compounds, which inhibit adipocyte differentiation, was able to isolate from the 
butanol fraction of a chokeberry extract amygdalin and prunasin as active com-
pounds [41]. These two cyanogenic glycosides suppress the expressions of peroxi-
some proliferator-activated receptor γ, CCAAT/enhancer-binding protein α (C/
EBPα), sterol regulatory element-binding protein 1c, fatty acid synthase (FAS), and 
adipocyte fatty-acid–binding protein (aP2) [42].
The most intensively studied compounds in cultivated black chokeberries are 
phenolic compounds, mainly anthocyanins, procyanidins and phenolic acids. The 
total phenolic content ranges from 3440 mg/100 g dry weight to 7849 mg/100 g dry 
weight, depending on cultivar, ripening stage at harvest, cultivation conditions or 
analytical methods used for the quantification [38]. Analysis of several chokeberry 
cultivars identified a higher polyphenolic content for the fruits of ‘Hugin’ cultivar 
compared to ‘Viking,’ ‘Galicjanka’ and ‘Nero’ cultivars [29]. There are differences 
in the polyphenols content in chokeberry products; for example, the pomace has a 
five-fold higher content compared to juice [16].
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Polymeric proanthocyanidins represent 66% of chokeberry polyphenols, while 
anthocyanins represent about 25%. The fruits contain up to 5181.60 mg/100 g dried 
weight polymeric procyanidins [43]. The constitutive unit is mainly (−)-epicat-
echin and the units are connected by C4▬C6 and C4▬C8 bonds (B-type bonds). The 
degree of polymerization ranges from 2 to 23 units. The main proanthocyanidins 
found in the fruits and bark of chokeberry are dimeric procyanidin B2 and procy-
anidin B5 and trimeric procyanidin C1 (Figure 1) [44].
Anthocyanins are a class of flavonoids that give blue, dark red or purple color of 
the fruits and they are important compounds for the biological activity of choke-
berries [38]. Black chokeberries have a higher content of anthocyanins than other 
berries, such as blackberries, strawberries or red raspberries [45]. Anthocyanins are 
found mainly in fruit skin [46]. They are represented by cyanidin glycosides such as 
Figure 1. 
Chemical structures of polyphenolic compounds from cultivated black-fruited chokeberries. (1) Procyanidin 
B2; (2) procyanidin B5; (3) procyanidin C1; (4) chlorogenic acid; (5) anthocyanins.
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cyanidin-3-glucoside, cyanidin-3-galactoside, cyanidin-3-xyloside and cyanidin-
3-arabinoside [43]. The study of the fruits of black chokeberry, ‘Viking’, ‘Nero’ and 
‘Galicjanka’ cultivars revealed that ‘Nero’ and ‘Viking’ cultivars had higher antho-
cyanin content. Cyanidin-3-galactoside and cyanidin-3-arabinoside are the major 
anthocyanins in chokeberries, while cyanidin-3-xyloside and cyanidin-3-glucoside 
are found in lower amounts [47]. The fruits also contain pelargonidin-3-arabinoside 
and pelargonidin-3-galactoside in trace amounts [17, 38]. Other anthocyanins such 
as cyanidin-3-pentoside-(epi)catechin, cyanidin-3,5-hexoside-(epi)catechin, and 
cyanidin-3-hexoside-(epi)cat-(epi)cat were identified in black chokeberry juice and 
powder [46].
The main phenolic acids in black chokeberries are chlorogenic and neochlo-
rogenic acids. They represent about 7.5% of fruit polyphenols [43]. In addition to 
chlorogenic and neochlorogenic acids, other phenolic acids such as cryptochlo-
rogenic acid, 3-O-p-coumaroylquinic acid and di-caffeic quinic acid have been 
reported in chokeberries [46]. Chokeberry juice contains a greater amount of these 
compounds than pomace [43]. Fruits of ‘Viking’ cultivar and wild chokeberry have 
a higher content of phenolic acids compared to fruits of ‘Nero’ and ‘Galicjanka’ 
cultivars [47].
Chokeberry also contains flavonol glycosides such as quercetin 3-O-galactoside, 
quercetin 3-O-rutinoside, quercetin 3-O-glucoside, quercetin 3-O-arabinoside, 
isorhamnetin 3-O-rutinoside or kaempferol 3-O-glucoside [48]. Other pheno-
lic compounds identified in chokeberry fruits and flowers are the flavanone 
eriodictyol-7-O-β-glucuronide and the flavonols quercetin-3-robinobioside and 
quercetin-3-vicianoside [49]. Even though the fruits were the most investigated for 
the polyphenols in their composition, black chokeberry leaves also contain these 
compounds, with a higher content in the young leaves compared to the old ones 
(Figure 1) [50].
4. Cardioprotective actions: in vivo and in vitro studies: clinical trials
Diseases of the circulatory system were reported to be the main cause of death 
in Europe and America [51, 52]. The affections of the circulatory system are related 
to high blood pressure, smoking, cholesterol and diabetes (the main pathologies of 
modern times), resulting in stroke or ischemic heart disease as the major patholo-
gies causing invalidity and death in the developed countries [53].
Obesity, sedentary lifestyle, diet, smoking and stress are the principal inducers 
of endothelial dysfunction and insulin resistance, which will later induce hyper-
tension and diabetes [54]. Thus, targeting endothelial dysfunction, insulin resis-
tance and the altered metabolic state represents important strategies for decreasing 
the incidence and complications of cardiovascular diseases, as well as the medical 
costs [53, 55].
As well known, the vascular endothelium is the single layer of cells that lines 
the internal lumen of blood vessels [54, 56]. A healthy endothelium is essential 
for the cardiovascular system and is considered nowadays an organ [53, 57]. It 
possesses several important functions such as relaxation of vascular smooth 
muscle cells, inhibition of platelet aggregation, limitation of leukocyte adhesion, 
regulation of the vascular tone, inhibition of vascular smooth proliferation, and 
specialized autocrine and paracrine secretion (producing and secreting vasoac-
tive, vasoprotective, angiogenic, inflammatory and thrombotic/antithrombotic 
molecules) [53, 55, 57]. It also produces growth factors and responds to physi-
cal and chemical signals. The term “endothelial dysfunction” is used not only 
to describe the impaired metabolism of nitric oxide (NO) or the imbalance of 
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endothelium-derived relaxing and constrictor factors, but also to describe an 
aberrant endothelium activation and abnormalities between endothelium and 
leukocytes, platelets and other regulatory molecules [53, 58, 59]. Thus, it plays an 
essential role in the pathogenesis of several cardiovascular (hypertension, athero-
sclerosis, systemic and pulmonary hypertension, etc.), as well as other diseases 
(inflammatory diseases or cancer) (Figure 2) [60–62].
Elevated oxidative stress is another major risk factor of cardiovascular patholo-
gies as an altered metabolic state will increase the reactive oxygen species (ROS) 
production, which will determine an increase in lipid peroxidation, inflammation, 
endothelial dysfunction, platelet aggregation and activation [63]. On endothelial 
cells, oxidative stress has been shown to immediately increase vessel damage. 
Moreover, the lesion caused by oxidative stress can affect the entire body’s organs 
and systems (Figure 2) [64].
Thus, it is important to find new therapeutic strategies to improve endothelial 
function and decrease ROS as strategies for the primary prevention of cardiovascu-
lar diseases in the ever-aging Western societies.
In the last decade, several plant bioactive substances (called nutraceuticals) 
have proven to have outstanding properties, which suggest that they could play an 
important role in preventing the onset and development of chronic diseases. The 
term nutraceutical refers to a natural bioactive compound with several properties, 
such as health promoting, disease preventing or medicinal properties [65].
Cultivated black chokeberry fruits have been discovered to contain an enor-
mous source of bioactive compounds such as antioxidants-especially polyphenols, 
flavonoids (anthocyanins, flavonols and flavanols), vitamins (C and E), minerals 
(potassium, magnesium and calcium), pectins, carotenoids and carbohydrates 
[16]. Moreover, the in vitro and in vivo studies have highlighted its antioxidant 
(one of the richest plants in antioxidants), anti-inflammatory, anti-proliferative, 
Figure 2. 
Main aspects regarding the development of cardiovascular disease events.
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anti-atherosclerotic, hypotensive, antiplatelet, gastroprotective, antimicrobial 
(antibacterial and antiviral), immunomodulatory and anti-tumor profile, mak-
ing it an excellent candidate for the prevention of cardiovascular and metabolic 
disorders [16, 66].
Herein, the main and the latest findings regarding the cardioprotective proper-
ties of cultivated black chokeberry will be presented and discussed (Figure 3).
4.1 Antioxidant properties
There are currently a large number of studies that presents the antioxidant activ-
ity of black chokeberry both in vivo (animal studies and clinical trials) and in vitro 
(isolated cells and cell lines) explaining the capability of different types of extracts 
obtained from this vegetal product to protect against free radicals. Black chokeberry 
fruits are considered to contain a huge level of antioxidants-more precisely vitamin C 
and polyphenols, such as anthocyanins, phenolic acids, tannins, flavanols, flavonols 
and flavonoids [16, 45, 67]. The antioxidant mechanism includes radical scaveng-
ing, inhibition of reactive oxygen and nitrogen species formation, of prooxidant 
enzymes, stimulation of antioxidant ones and most probably cellular signaling to 
manage the enzymes and antioxidant substance levels [68]. The berries highlighted 
the highest antioxidant capacity among other berries and fruits investigated via the 
oxygen radical absorbing capacity (ORAC) assay [28, 38, 69, 70]. Moreover, it was 
noted that the pomace compared with the berries or the juice has a higher antioxidant 
capacity (being five times more concentrated than the juice) and the highest content 
of phenolic compounds (mainly polymeric proanthocyanidins and (−)-epicatechin) 
[43]. On the other hand, Rop et al. [71], showed the same high antioxidant property 
for the fruit product, pomace, fresh berry fruits and juice [16, 71]. An important 
amendment is the fact that the antioxidant activity levels and the polyphenols 
concentration are species dependent [16].
A recent in vivo study, published in 2019, showed the additive effect of choke-
berry and walnut in increasing the expression of antioxidant enzyme genes in the 
Figure 3. 
The main cardioprotective effects of cultivated black chokeberry and its mechanism of action.
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liver and decreasing lipid peroxidation in the liver, serum and kidneys in an aging 
mouse model [72]. The study performed by Jo et al. [73] described that dietary 
supplementation with Aronia extract increased the lifespan and improved the 
oxidative injuries related to the age in Drosophila melanogaster. Other in vitro studies 
outlined an increased antioxidant profile by decreasing the levels of ROS after 
incubation with Aronia melanocarpa bioactive compounds [74, 75]. Moreover, a 
decreased level of plasma lipid peroxidation was observed in vitro, after treatment 
with ziprasidone [76]. The antioxidant effect was also evidentiated in humans, as 
the black chokeberry juice supplementation decreased the exercise-induced oxida-
tive damage to red blood cells in rowers [77].
The antioxidant activity is in general attributed to the polyphenolic compounds 
[3, 78]. It was observed that proanthocyanidin and anthocyanin content in berries, 
as well as neochlorogenic acid, cyaniding 3-arabinoside and (−)-epicatechin, are 
the main substances responsible for this action [71, 79].
4.2 Anti-inflammatoSry effect
Vascular inflammation is a primary key step process underlying endothelial 
dysfunction and later atherosclerosis [59]. It is responsible for endothelial activa-
tion, which will further stimulate the leukocytes’ recruitment [56]. Moreover, it 
is a self-maintaining process, which is mediated through the expression of several 
molecules such as cell adhesion molecules (ICAM and VCAM), cytokines, neutro-
phils, fibrinogen, C-reactive protein, etc. [68]. Apart from endothelial dysfunction, 
it will induce smooth muscle cell migration, vascular calcification, oxidative stress, 
degradation of extracellular matrix and collagen, elastolysis and increased activity 
of metalloproteinases. Vascular inflammation was observed in patients with hyper-
tension, metabolic syndrome, diabetes, infections, preeclampsia, coronary heart 
disease or peripheral arterial disease [58, 62]. Thus, the anti-inflammatory effect 
exhibited by several bioactive natural, synthetic or semi-synthetic compounds is 
important for the prevention of chronic diseases (especially the cardiovascular, 
metabolic and immune system disorders) and also for decreasing their complica-
tions [16]. Supplementation with black chokeberry extract for patients who suffered 
myocardial infarction and are under treatment with statins decreased the plasmatic 
concentration of several inflammatory biomarkers such as C-reactive protein 
(CRP), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion mol-
ecule (ICAM), vascular cell adhesion molecule (VCAM) and interleukin 6 (IL-6). 
Moreover, adiponectin concentration (an anti-inflammatory cytokine) was found 
to be increased [80]. The study performed by Zapolska-Downar et al., in 2012, on 
TNF-α–treated human aortic endothelial cells (HAECs) highlighted the fact that 
various concentrations of Aronia extract decreased the expression of ICAM-1, 
VCAM-1, the phosphorylation of NF-κB p65 and intracellular ROS production [26].
Other research groups reported that black chokeberry extract induces a vaso-
relaxation of coronary arterial rings, which is dose-dependent and endothelium-
dependent, compared with other extracts (bilberry and elderberry) [81].
Recently, Iwashima et al. [82], showed that Aronia extract decreased TNF-α–
induced monocyte/endothelial adhesion and decreased VCAM-1 expression, 
although it did not affect ICAM-1 expression on a vascular endothelial inflam-
mation model of human umbilical vein endothelial cells (HUVECs). Moreover, it 
lowered the phosphorylation of signal transducer and activator of transcription 
3 (STAT3), its nuclear levels and the interferon regulatory transcription factor-1 
(IRF1) nuclear level. Thus, the researchers concluded that Aronia extract could 
exert an anti-atherosclerotic effect through the inhibition of STAT3/IRF1 pathway 
in vascular endothelial cells [82].
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Lee et al. [83] highlighted the anti-neuroinflammatory effect of an ethanolic 
extract of Aronia in a mouse model of Alzheimer’s disease. Aronia extract signifi-
cantly reduced the generation of NO, as well as mRNA levels of iNOS (inducible 
nitric oxide synthase), COX-2 (cyclooxygenase 2), IL-1β (interleukin-1 beta) and 
TNF-α (tumor necrosis factor alpha), suggesting its neuroprotective effect against 
the development of Alzheimer’s disease [83].
Wei et al. [84] showed that the anthocyanins from black chokeberry delayed the 
degenerative changes of brain, related to aging, in an aged mouse model, possibly 
by reducing inflammation, regulating the balance of redox system and inhibiting 
DNA damage [84].
In another study, it was observed that the administration of Aronia cold-pressed 
juice and oven-dried black chokeberry powder by patients with mildly elevated 
blood pressure levels reduced only the levels of TNF-α and IL-10 and did not influ-
ence other inflammatory markers [85].
The anti-adhesion effect of Aronia extract can be due to the presence of antho-
cyanins (alone or by a synergistic effect), more precisely cyaniding-3-glucoside, 
cyaniding-3-galactoside, cyaniding-3-arabinoside, peonidin-3-glucoside and 
delphinidin-3-glucoside [86].
Moreover, the anti-apoptotic effect of Aronia extract was also showed in an 
animal model of cardiomyoblasts [87]. In diabetic patients, the reversing of athero-
sclerosis development by Aronia polyphenols was also showed through augmenting 
the immune defenses and reducing inflammation, as the extract decreased the 
monocyte and granulocyte levels responsible for inflammation and also the number 
of lymphocytes, thus blocking the formation of atherosclerotic lesions [23, 88].
4.3 Hypotensive properties
Chronic inflammation can lead to cardiovascular diseases characterized by high 
blood pressure levels, altered metabolism of lipids, endothelial dysfunction, oxida-
tive stress, etc. Endothelial dysfunction can be a cause, as well as a consequence of 
hypertension [59]. Thus, due to multiple mechanisms of action, black chokeberry 
can induce a cardioprotection by having positive effects on multiple risk factors for 
cardiovascular diseases (e.g., antioxidant effect, anti-inflammatory, hypolipidemic, 
antithrombotic, etc.) [16, 26, 89].
Over the years, the blood pressure lowering effects of black chokeberry were 
highlighted in several studies and nowadays black chokeberry preparations are 
recommended as a nutritional supplement in the management of essential arterial 
hypertension [16]. In one study, spontaneous hypertensive rats that were treated 
with commercial Aronia extract had decreased blood pressure levels compared with 
controls [90], although the effect was term-limited and maximal 3 h after intake. 
Other studies suggested that Aronia polyphenols could induce a positive effect on 
blood vessels by stimulating NO synthesis in endothelial cells (via activation of 
eNOS), through a mechanism related to ACE inhibitors (angiotensin I-converting 
enzyme inhibitors) and endothelium-dependent [68, 91]. Sihora et al. studied the 
effects of 2 months administration of black chokeberry preparation in patients 
with metabolic syndrome on the activity of ACE. They observed a 25% decrease of 
ACE after 1 month of administration and 30% decrease after the second month. 
Moreover, systolic blood pressure, diastolic blood pressure and CRP levels cor-
related positively with the activity of ACE [92]. The studies performed by Bell et al. 
[81] highlighted the vasoactive and vasoprotective potential of black chokeberry 
extract on the coronary arteries, due to the high concentrations of anthocyanins. 
The following bioactive substances were found to be responsible for the vasorelax-
ation and the endothelial protective effects: coumaric acid (the most potent), ferulic 
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acid, caffeic acid and chlorogenic acid [92]. Moreover, Aronia induced a protective 
action in aorta and coronary arteries against atherogenic changes [93, 94].
A double-blind, placebo-controlled study performed by Naruszewicz et al. [80] 
showed that black chokeberry polyphenols decreased the severity of inflammation in 
patients after myocardial infarction and thus, Aronia can be used as a strategy treat-
ment for the secondary prevention of ischemic heart disease [80]. Black chokeberry 
flavonoids significantly decreased serum 8-isoprostanes and oxidated LDL (formed as 
a consequence of the action of oxidative stress in the vascular wall that are contribut-
ing to the formation of foam cells, the basis of atherosclerotic lesions) [95]. Moreover, 
it decreased the levels of adhesion molecules (ICAM, VCAM and MCP-1) compared 
with the control group and increased the level of adiponectin, an anti-inflammatory 
molecule [80]. Anthocyanins (mostly conjugated cyanidins and chlorogenic acid) 
from black chokeberry juice were found to be potent stimulators of endothelial NO 
formation via Sirc/PI3-kinase Akt pathway, in a study performed by Kim et al. [96].
The study performed by Loo et al. [85] showed that consumption of chokeberry 
products can modestly lower blood pressure levels and decrease low-grade inflam-
mation in hypertensive patients (under no regular use of anti-hypertensive drugs) 
with mildly elevated blood pressure levels.
4.4 Lipid-lowering and anti-obesity effects
Several studies, including large clinical trials, have showed over the time the 
relationship between LDL cholesterol, triglycerides and the development and 
progression of atherosclerosis. Moreover, it is well known that hyperlipidemia is 
one of the major risk factors for developing undesirable cardiovascular events [68]. 
Black chokeberry products had been reported to manifest lipid-lowering proper-
ties and anti-obesity effect in culture cells, in animal as well as in human studies. 
Qin et al. [97] showed that a dose of 10 or 20 mg/kg/body weight of anthocyanin 
attenuates weight gain, decreases triglycerides and cholesterol and modulates 
insulin resistance in Wistar rats under a fructose-rich diet of 6 weeks. Moreover, 
it decreased TNF-α and IL-6 [97]. The black chokeberry pomace administered in 
Polish Merino lambs decreased glucose and total cholesterol levels and increased 
HDL [98]. The juice administered ad libitum for 28 days decreased glucose, insulin 
and body weight in C57BL/6JmsSIc and KK-Ay mice [99]. Another study performed 
by Daskalova et al. [94] on male Wistar rats who received a daily dose of 25 ml com-
mercial juice for 90 days showed a decrease in LDL and also retarded age-related 
changes in the aortic wall. Ciocoiu et al. [100] showed a decrease of total choles-
terol, systolic and diastolic blood pressure levels and an increased HDL value after 
8 weeks administration of an ethanol extract of black chokeberry.
Results from clinical trials have shown that administration of 100 ml juice before 
meal decreased the blood glucose levels of 37 healthy subjects [101]. A 12-week 
randomized, placebo-controlled trial showed that consummation of 500 mg 
Aronia extract although did not changed blood pressure levels or inflammatory 
and oxidative stress biomarkers, it decreased total and LDL cholesterol in healthy 
adults former smokers. The cholesterol-lowering capacity was closely linked with 
cyanidin-3-O-galactoside and peonidin-3-O-galactoside urinary levels [102]. 
Kardum et al. [103] showed that 100 ml of glucomannan-enriched Aronia juice-
based supplement decreased the body mass index, waist circumference and systolic 
blood pressure, concluding that the juice had a positive effect on cellular oxidative 
damage, anthropometric indices of obesity and blood pressure levels.
In 2016, Shin et al. observed that adipogenesis in 3 T3-L1 preadipocytes was 
blocked after administration of a black chokeberry extract. Moreover, the expres-
sion of mRNA levels of some adipogenesis key genes was impacted and that the 
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levels of PPARϒ (peroxisome proliferator-activated receptor ϒ), FABP4 (fatty acid–
binding protein 4), adiponectin, MCP-1 (monocyte chemoattractant protein-1) and 
leptin were decreased [104].
Other studies performed concluded that anthocyanins may contribute to the 
prevention of obesity by lowering the sugar and lipid absorption in the digestive 
system [16, 105]. Although the mechanism underlying the lipid-lowering effect 
is not completely elucidated, it seems that the blocking of cholesterol absorption 
(by flavonoids), increased lipoprotein catabolism (by cyanidin), inhibition of 
3-hydroxy-3-methylglutaryl-CoA reductase and thus decreased synthesis of choles-
terol (by flavonoids) could explain this effect [68].
4.5 Anti-diabetic effect
Several studies describe the hypoglycemic effect of black chokeberry  
[16, 98, 106–108]. Moreover, its property of decreasing the insulin resistance was 
also highlighted. It seems that Aronia extracts can lower the risk factors associ-
ated with insulin resistance, by decreasing inflammation and adipogenesis and by 
modulating several pathways linked to insulin signaling [92, 97]. As a general view, 
metabolic disorders, more specifically plasma glucose and the lipid profile, were 
improved after long-term juice consumption [106–108]. It was observed that poly-
phenolic compounds can decrease blood glucose levels by inhibiting α-glucosidase 
and α-amylase activity and, thus, controlling the postprandial hyperglycemia [16]. 
Anthocyanins (more specifically cyaniding 3-rutinoside) might inhibit intestinal 
α-glucosidase and might slow down the absorption of sugars [106, 109, 110]. 
Moreover, anthocyanins were found to exert a positive action on normalizing the 
carbohydrate metabolism in diabetic patients and rats, throughout several mecha-
nisms such as reversing the beta cells’ integrity and physiology and stimulating the 
release of insulin [111]. Chlorogenic acid was found to be the most potent inhibitor 
of pancreatic α-amylase [16]. Other studies postulated that the antidiabetic effect 
of black chokeberry juice may be due to the cyaniding 3,5-diglucoside inhibition of 
DPP IV (dipeptidyl peptidase IV) [112]. It seems that in humans, black chokeberry 
juice can be an excellent natural alternative therapeutic strategy for the treatment 
of metabolic syndrome disorders, the dose varying from 100 ml to 300 ml per day, 
for at least 3 months [16].
A recent study, published in 2019, showed the anti-adipogenic effect of cyanid-
ing-3-O-galactoside–enriched black chokeberry extract in C57BL/6 obese mice. 
The extract reduced the serum levels of insulin, leptin, triglyceride, LDL and total 
cholesterol and suppressed adipogenesis by decreasing the expression of several key 
proteins [113].
The study performed by Jakovljevic et al. [114] on a rat model with metabolic 
syndrome highlighted the fact that 4-week administration of Aronia extract man-
aged to reduce blood pressure levels and to induce benefits on the heart function. 
It also improved glucose tolerance and oxidative stress levels and attenuated the 
pathological alterations of the liver, thus conferring an excellent cardioprotection, 
alone or in combination with other dietary regimens [114]. A fermented chokeberry 
extract administered for 8 weeks in obese mice decreased weight gain and increased 
glucose tolerance and insulin sensitivity. These results also led to the conclusion that 
the anti-obesity effect was not closely correlated with the cyaniding content [115].
4.6 Effects on erythrocytes
Studies showed that the anti-oxidative effect of black chokeberry may impact 
erythrocyte’s proper functioning [23]. The juice increased the protection against 
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oxidation in erythrocyte membranes of 25 healthy women who drank 100 ml daily 
for 3 months [103]. The same effect (anti-oxidative effect on erythrocytes and 
increased PUFA concentration) was observed in obese women who drank 100 ml 
juice with glucomannan for 4 weeks [103]. Moreover, in patients with hypercho-
lesterolemia, Aronia extract decreased cholesterol level and lipid peroxidation in 
erythrocytes, improved the rheological properties of red cells and increased their 
membrane fluidity [116].
4.7 Effects on neutrophils
As neutrophils produce high concentrations of ROS, this impacts the tissue-
damaging effects of inflammatory reactions. The study performed by Zielinska-
Przyjemska et al. [117] showed that the oxidative metabolism of neutrophils 
decreased after treatment with Aronia juice, both in non-obese and in obese 
patients.
4.8 Antithrombotic properties
Black chokeberry exhibited in vitro strong anticoagulant properties by prolong-
ing blood clotting times (APTT, prolonged PT and TT) and by decreasing the 
maximal velocity of fibrin polymerization in human plasma [16, 118]. Malinowska 
et al. showed its action on clot formation and fibrin lysis in patients with hyperho-
mocysteinemia [74]. Black chokeberry proved to possess properties in inhibiting 
also the platelet aggregation [119], as the extract decreased in vitro several steps of 
platelet activation, such as adhesion of platelets to collagen and platelet aggregation. 
Moreover, it decreased the production of ROS in resting blood platelets and in those 
activated by thrombin [119]. Sikora et al. [92] noted that 1 month of administration 
of Aronia extract in men did not influence the number of platelets in the blood; the 
extract led to prolonging the time required to reach the maximal aggregation. The 
study performed by Ryszawa et al. [120] assessed the effects of Aronia extract on 
ROS production and aggregation in the thrombocytes of smoker patients with high 
cardiovascular risk factors, such as hypertension, diabetes and hypercholesterolemia, 
who had an increased production of ROS, compared with the control group. The 
Aronia supplementation managed to neutralize the difference in ROS production 
between the studied group and the control group and induced significant anti-aggre-
gation effects dependent on the concentration, in both groups, concluding that these 
effects might be independent of its capacity of modulating ROS production [120].
5. Conclusions and perspectives
From all the information presented above, one can conclude that black choke-
berry is an extremely rich source of bioactive molecules that are offering an excel-
lent cardioprotection among other fruits and that can be used in both primary and 
secondary prevention of cardiovascular events. Despite the low bioavailability 
of polyphenols and their variability, they are exceptionally important for their 
health-promoting properties. Based on the present findings, it can be definitely 
included in a healthy daily diet. However, much more research is needed to com-
pletely understand the exact mechanisms as well as the full-length actions of black 
chokeberry, especially in humans. Complete bioavailability studies are required 
concerning Aronia bioactive molecules. Moreover, the investigation of the risk of 
tissue accumulation, as well as appreciation of the risk/benefit ratio in humans, will 
be extremely beneficial. The recommended daily intake should also be established.
Natural Products - From Bioactive Molecules to Human Health
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